Bellecapital International Ltd. Gilead Sciences, Inc. Transaction History

Bellecapital International Ltd.

$484 Million
Q3 2024

A detailed history of Bellecapital International Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bellecapital International Ltd. holds 18,705 shares of GILD stock, worth $1.76 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

18,705

Previous 11,955 56.46%

Holding current value

$1.76 Million

Previous $820,000 91.1%

% of portfolio

0.32%

Previous 0.18%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$66.59 - $83.99 $449,482 - $566,932	6,750 Added 56.46%	18,705 $1.57 Million
Q2 2024 Jul 19, 2024	BUY	$63.15 - $72.88 $358,439 - $413,666	5,676 Added 90.4%	11,955 $820,000
Q1 2024 May 03, 2024	BUY	$71.58 - $87.29 $97,849 - $119,325	1,367 Added 27.83%	6,279 $459,000
Q4 2023 Jan 22, 2024	SELL	$73.27 - $83.09 $390,748 - $443,118	-5,333 Reduced 52.05%	4,912 $397,000
Q3 2023 Oct 17, 2023	SELL	$73.94 - $80.67 $23,512 - $25,653	-318 Reduced 3.01%	10,245 $767,000
Q2 2023 Jul 07, 2023	BUY	$76.01 - $86.7 $78,898 - $89,994	1,038 Added 10.9%	10,563 $814,000
Q1 2023 Apr 25, 2023	SELL	$77.31 - $88.08 $379,514 - $432,384	-4,909 Reduced 34.01%	9,525 $790,000
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $128,192 - $184,039	-2,057 Reduced 12.47%	14,434 $1.24 Million
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $276,682 - $316,042	4,647 Added 39.24%	16,491 $1.02 Million
Q2 2022 Jul 27, 2022	BUY	$57.72 - $65.01 $683,635 - $769,978	11,844 New	11,844 $732,000
Q2 2020 Jul 16, 2020	SELL	$72.34 - $84.0 $588,630 - $683,508	-8,137 Closed	0 $0
Q1 2020 Apr 24, 2020	SELL	$62.63 - $80.22 $390,310 - $499,931	-6,232 Reduced 43.37%	8,137 $608,000
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $170,749 - $187,818	2,771 Added 23.89%	14,369 $934,000
Q2 2019 Jul 22, 2019	BUY	$61.87 - $69.38 $36,193 - $40,587	585 Added 5.31%	11,598 $784,000
Q1 2019 Apr 23, 2019	BUY	$62.53 - $70.05 $688,642 - $771,460	11,013 New	11,013 $716,000
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $490,213 - $597,624	-6,730 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $478,839 - $562,089	6,730	6,730 $482,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.

Account

Bellecapital International Ltd. Gilead Sciences, Inc. Transaction History